4//SEC Filing
Roche Corleen M. 4
Accession 0001104659-21-053339
CIK 0001472012other
Filed
Apr 20, 8:00 PM ET
Accepted
Apr 21, 9:38 PM ET
Size
5.4 KB
Accession
0001104659-21-053339
Insider Transaction Report
Form 4
Immunome Inc.IMNM
Roche Corleen M.
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-04-19+125,000→ 125,000 totalExercise: $27.53Exp: 2031-04-19→ Common Stock (125,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option shall vest on April 19, 2022, and the remaining 75% of shares subject to the option shall vest in equal monthly installments for the 36 months thereafter.
Documents
Issuer
Immunome Inc.
CIK 0001472012
Entity typeother
Related Parties
1- filerCIK 0001857905
Filing Metadata
- Form type
- 4
- Filed
- Apr 20, 8:00 PM ET
- Accepted
- Apr 21, 9:38 PM ET
- Size
- 5.4 KB